Z Gastroenterol 2008; 46 - A6
DOI: 10.1055/s-2008-1081513

Role of Klebsiella Oxytoca in non-hemorrhagic antibiotic-associated diarrhea

I Zollner-Schwetz 1, C Högenauer 1, M Joainig 1, P Weberhofer 1, G Gorkiewicz 1, TA Hinterleitner 1, R Krause 1
  • 1Infektiologie, Klinische Abteilung für Pulmonologie, Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Graz

Introduction: Recently, Klebsiella oxytoca was found to be the causative for antibioticassociated hemorrhagic colitis (AAHC). Whether K. oxytoca plays a role in non-hemorrhagic antibiotic-associated diarrhea (AAD) is unknown. The aim of our study was therefore to investigate whether this bacterium is associated with AAD.

Methods: 371 patients were recruited into 4 study groups: (1) group AAD (patients receiving antibiotics and experiencing diarrhea, n=107), (2) group A+D- (patients receiving antibiotics but not experiencing diarrhea, n=93), (3) group A-D+ (patients experiencing acute onset diarrhea but not receiving antibiotics, n=60), (4) group A-D- (control patients, n=111). Stool samples were plated on MacConkey agar and K. oxytoca was identified by API 20E. C. difficile was detected by toxin A/B antigen test. K. oxytoca strains were tested for cytotoxicity using a cell-culture assay.

Results: There was no significant difference in distribution of K. oxytoca in the 4 groups. 3 cases of AAHC were recorded. A total of 15 K. oxytoca strains were isolated during the study period in all patient groups. Five of these strains were found to be toxin – producing.

AAD

A+D-

A-D-

A-D+

Number of patients

104

93

111

60

Positive for

1/104

1/93

5/111

5/60

K. oxytoca

(0,9%)

(1,1%)

(4,5%)

(8,3%)

Positive for

12/104

0/93

0/111

2/60

C. difficile toxin

(11,5%)

(0%)

(0%)

(33%)

Conclusion: In contrast to AAHC, K. oxytoca is not associated with non-hemorrhagic AAD.

Testing for K. oxytoca is therefore only warranted in patients with bloody diarrhea and a history suspicious of AAHC.